189 related articles for article (PubMed ID: 2253865)
1. [Heterogeneity of leukemia cell phenotype. I. Variants of hetero- phenotype in relation to myeloid and erythrocytic markers of leukemic cells in acute leukemia and blast crisis of chronic myeloproliferative disorders].
Kemnitz J; Helmke M; Frend M; Bür T; Dominis M; Horitz H
Gematol Transfuziol; 1990 Aug; 35(8):9-14. PubMed ID: 2253865
[No Abstract] [Full Text] [Related]
2. [Heterogeneity of leukemic cell phenotype. II. Variants of hetero- phenotype in relation to myeloid and megakaryocytic markers of leukemia cells in acute leukemia and blast crisis of chronic myeloproliferative disorders].
Kemnitz J; Frend M; Dominis M
Gematol Transfuziol; 1990 Aug; 35(8):15-8. PubMed ID: 2253854
[No Abstract] [Full Text] [Related]
3. Clinical and cytogenetic correlations of abnormal megakaryocytopoiesis in patients with acute leukemia and chronic myelogenous leukemia in blast crisis.
Lee EJ; Schiffer CA; Tomiyasu T; Testa JR
Leukemia; 1990 May; 4(5):350-3. PubMed ID: 2388480
[TBL] [Abstract][Full Text] [Related]
4. DNMT3A mutations in myeloproliferative neoplasms.
Stegelmann F; Bullinger L; Schlenk RF; Paschka P; Griesshammer M; Blersch C; Kuhn S; Schauer S; Döhner H; Döhner K
Leukemia; 2011 Jul; 25(7):1217-9. PubMed ID: 21537334
[No Abstract] [Full Text] [Related]
5. Blast Transformation in Myeloproliferative Neoplasms: Risk Factors, Biological Findings, and Targeted Therapeutic Options.
Iurlo A; Cattaneo D; Gianelli U
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013941
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 expression in acute leukemia.
Aref S; Mabed M; El-Sherbiny M; Selim T; Metwaly A
Hematology; 2006 Feb; 11(1):31-4. PubMed ID: 16522546
[TBL] [Abstract][Full Text] [Related]
7. [Clonal growth of erythroid progenitor cells from normal bone marrow exposed to leukocytes from the blood of patients with acute leukemia].
Hansz J; Kozłowska-Skrzypczak M
Pol Arch Med Wewn; 1988 Feb; 79(2):75-83. PubMed ID: 2980651
[No Abstract] [Full Text] [Related]
8. Growth of normal versus leukemic bone marrow cells in long term culture from acute lymphoblastic and myeloblastic leukemias.
Schiró R; Coutinho LH; Will A; Chang J; Testa NG; Dexter TM
Blut; 1990 Nov; 61(5):267-70. PubMed ID: 2271773
[TBL] [Abstract][Full Text] [Related]
9. Enforced differentiation of Dnmt3a-null bone marrow leads to failure with c-Kit mutations driving leukemic transformation.
Celik H; Mallaney C; Kothari A; Ostrander EL; Eultgen E; Martens A; Miller CA; Hundal J; Klco JM; Challen GA
Blood; 2015 Jan; 125(4):619-28. PubMed ID: 25416276
[TBL] [Abstract][Full Text] [Related]
10. Differences between blastic chronic myeloid leukemia and Ph-positive acute leukemia.
Berger R
Leuk Lymphoma; 1993; 11 Suppl 1():235-7. PubMed ID: 8251902
[TBL] [Abstract][Full Text] [Related]
11. Utility of the Technicon H-1 flags in the detection of peripheral blood blast cells of paediatric acute leukaemia patients.
Fernández-Castro M; Viloria A
Acta Haematol; 1995; 93(1):9-12. PubMed ID: 7725855
[TBL] [Abstract][Full Text] [Related]
12. Progression to B acute lymphoblastic leukemia in 8p11 myeloproliferative syndrome with t(6;8)(q27;p12).
Nakamura F; Seo S; Nannya Y; Ayabe R; Takahashi W; Handa T; Arai H; Iso H; Nakamura Y; Nakamura Y; Sasaki K; Ichikawa M; Imai Y; Ogawa S; Mitani K
Int J Hematol; 2023 Sep; 118(3):388-393. PubMed ID: 36930401
[TBL] [Abstract][Full Text] [Related]
13. [Hybrid leukemia among acute childhood leukemias].
Koehler M; Bubała H
Pol Tyg Lek; 1992 Apr 20-27; 47(16-17):347-9. PubMed ID: 1437751
[TBL] [Abstract][Full Text] [Related]
14. Activating FLT3 mutations are detectable in chronic and blast phase of chronic myeloproliferative disorders other than chronic myeloid leukemia.
Lin P; Jones D; Medeiros LJ; Chen W; Vega-Vazquez F; Luthra R
Am J Clin Pathol; 2006 Oct; 126(4):530-3. PubMed ID: 16938665
[TBL] [Abstract][Full Text] [Related]
15. Patterns of hematopoietic lineage involvement in children with neurofibromatosis type 1 and malignant myeloid disorders.
Miles DK; Freedman MH; Stephens K; Pallavicini M; Sievers EL; Weaver M; Grunberger T; Thompson P; Shannon KM
Blood; 1996 Dec; 88(11):4314-20. PubMed ID: 8943868
[TBL] [Abstract][Full Text] [Related]
16. Cell signaling in putative leukemic stem cells and blast population in acute myeloid leukemia.
Garg S; Shanmukhaiah C; Ghosh K; Madkaikar M
Leuk Lymphoma; 2016 Sep; 57(9):2195-8. PubMed ID: 26700494
[No Abstract] [Full Text] [Related]
17. P-glycoprotein and drug resistance in acute leukemias and in the blastic crisis of chronic myeloid leukemia.
Carulli G; Petrini M; Marini A; Vaglini F; Caracciolo F; Grassi B
Haematologica; 1990; 75(6):516-21. PubMed ID: 1982999
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 (Cox-2) and blast cells of patients with acute leukemia.
Vincent C; Donnard M; Bordessoule D; Turlure P; Trimoreau F; Denizot Y
Leuk Res; 2008 Apr; 32(4):671-3. PubMed ID: 17881051
[No Abstract] [Full Text] [Related]
19. Fluorescence in situ hybridization (FISH) detection of trisomy 8 in myeloid cells in chronic myeloid leukemia (CML): a study of archival blood and bone marrow smears.
Nguyen PL; Arthur DC; Litz CE; Brunning RD
Leukemia; 1994 Oct; 8(10):1654-62. PubMed ID: 7934161
[TBL] [Abstract][Full Text] [Related]
20. Expression of complement regulatory proteins CR1, DAF, MCP and CD59 in haematological malignancies.
Guc D; Canpinar H; Kucukaksu C; Kansu E
Eur J Haematol; 2000 Jan; 64(1):3-9. PubMed ID: 10680700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
